Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000192131 | SCV001140668 | uncertain significance | Alexander disease | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000192131 | SCV001369932 | uncertain significance | Alexander disease | 2019-01-28 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3,PP2,PM1,PP5. |
Labcorp Genetics |
RCV000056895 | SCV002294229 | benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000056895 | SCV002545940 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | GFAP: BS2 |
Victorian Clinical Genetics Services, |
RCV000192131 | SCV002766799 | likely benign | Alexander disease | 2022-03-31 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as likely benign. Following criteria are met: 0308 - Population frequency for this variant is out of keeping with known incidence of Alexander disease (MIM#203450). (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Breakthrough Genomics, |
RCV000056895 | SCV005192918 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Epithelial Biology; Institute of Medical Biology, |
RCV000056895 | SCV000088008 | not provided | not provided | no assertion provided | not provided | ||
Gene |
RCV000192131 | SCV000222992 | pathogenic | Alexander disease | 2015-01-08 | no assertion criteria provided | literature only |